daunorubicin has been researched along with Adrenal Cortex Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gayer, B; Knoll, E; Kohen, F; Kulik, T; Sharon, O; Somjen, D; Stern, N | 1 |
Feller, N; Hoekman, K; Kuiper, CM; Linn, SC; Pinedo, HM; Popp-Snijders, C; Verheul, HM; Wolthers, BG | 1 |
2 other study(ies) available for daunorubicin and Adrenal Cortex Cancer
Article | Year |
---|---|
Carboxy derivatives of isoflavones as affinity carriers for cytotoxic drug targeting in adrenocortical H295R carcinoma cells.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Antibiotics, Antineoplastic; Cell Survival; Creatine Kinase; Daunorubicin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Estrogens; Female; Humans; Isoflavones; Neoplasm Proteins; Rats; Rats, Wistar; Receptors, Estrogen; Transcription, Genetic; Tumor Cells, Cultured | 2003 |
A patient with adrenocortical carcinoma: characterization of its biological activity and drug resistance profile.
Topics: Adrenal Cortex Neoplasms; Adult; Androgens; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Etoposide; Genes, p53; Glucocorticoids; Humans; Male; Mineralocorticoids; Mitotane; Neoplasm Proteins; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles; Vincristine | 1997 |